Medikaloka Hermina Revenue vs. Return On Equity

HEAL Stock  IDR 1,470  85.00  6.14%   
Based on the key profitability measurements obtained from Medikaloka Hermina's financial statements, Medikaloka Hermina PT may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Medikaloka Hermina's ability to earn profits and add value for shareholders.
For Medikaloka Hermina profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medikaloka Hermina to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medikaloka Hermina PT utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medikaloka Hermina's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medikaloka Hermina PT over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Medikaloka Hermina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medikaloka Hermina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medikaloka Hermina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Medikaloka Hermina Return On Equity vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Medikaloka Hermina's current stock value. Our valuation model uses many indicators to compare Medikaloka Hermina value to that of its competitors to determine the firm's financial worth.
Medikaloka Hermina PT is rated as one of the top companies in revenue category among its peers. It also is one of the top stocks in return on equity category among its peers . The ratio of Revenue to Return On Equity for Medikaloka Hermina PT is about  Huge . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medikaloka Hermina's earnings, one of the primary drivers of an investment's value.

Medikaloka Revenue vs. Competition

Medikaloka Hermina PT is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 37.83 Trillion. Medikaloka Hermina retains roughly 5.82 Trillion in revenue claiming about 15% of equities under Health Care industry.

Medikaloka Return On Equity vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Medikaloka Hermina

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
5.82 T
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Medikaloka Hermina

Return On Equity

 = 

Net Income

Total Equity

 = 
0.14
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Medikaloka Return On Equity Comparison

Medikaloka Hermina is currently under evaluation in return on equity category among its peers.

Medikaloka Hermina Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Medikaloka Hermina, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medikaloka Hermina will eventually generate negative long term returns. The profitability progress is the general direction of Medikaloka Hermina's change in net profit over the period of time. It can combine multiple indicators of Medikaloka Hermina, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. The company was founded in 1999 and is based in Jakarta, Indonesia. Medikaloka Hermina operates under Medical Care Facilities classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 10547 people.

Medikaloka Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Medikaloka Hermina. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medikaloka Hermina position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medikaloka Hermina's important profitability drivers and their relationship over time.

Use Medikaloka Hermina in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medikaloka Hermina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medikaloka Hermina will appreciate offsetting losses from the drop in the long position's value.

Medikaloka Hermina Pair Trading

Medikaloka Hermina PT Pair Trading Analysis

The ability to find closely correlated positions to Medikaloka Hermina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medikaloka Hermina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medikaloka Hermina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medikaloka Hermina PT to buy it.
The correlation of Medikaloka Hermina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medikaloka Hermina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medikaloka Hermina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medikaloka Hermina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Medikaloka Hermina position

In addition to having Medikaloka Hermina in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cancer Fighters Thematic Idea Now

Cancer Fighters
Cancer Fighters Theme
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Medikaloka Stock

To fully project Medikaloka Hermina's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Medikaloka Hermina at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Medikaloka Hermina's income statement, its balance sheet, and the statement of cash flows.
Potential Medikaloka Hermina investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Medikaloka Hermina investors may work on each financial statement separately, they are all related. The changes in Medikaloka Hermina's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medikaloka Hermina's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.